QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings (QA-DDS)

April 1, 2019 updated by: Jamie Studts
Using a single-arm trial design, this study will examine the feasibility and acceptability of evaluating QuitAdvisorDDS, a clinical decision support software application designed to facilitate implementation of evidence-based tobacco treatment interventions into the dental setting. The study will examine the feasibility and acceptability of evaluating the impact of the QuitAdvisorDDS tool on patient outcomes related to tobacco use and cessation attempts as well as provider knowledge, attitudes, and practices regarding tobacco treatment. Practitioners (dentists and hygienists) will complete surveys at baseline and follow-up, while patients will complete surveys at baseline and 1-month follow-up. An embedded substudy will also evaluate the feasibility and acceptability of collecting biospecimens (saliva) to serve as biochemical verification of smoking status.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

248

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40536-0086
        • University of Kentucky

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Receives dental care from a participating practitioner;
  • Is age 18 or older;
  • Self-reports tobacco use within the past month;
  • Willing to comply with all study procedures and be available for the duration of the study;
  • Willing to provide verbal informed consent;
  • Has access to a telephone, and agrees to receive text messages, emails, or telephone calls related to the study. (The patient's preferred method of contact will be ascertained).
  • Willing to be contacted on a regular basis by each of these entities: the practice;Regional Coordinators (RC) and/or University of Kentucky (UK) researchers; and
  • Willing to provide contact information of one person living at a different address who will know the patient's whereabouts in the event the patient cannot be reached.

Exclusion Criteria:

  • Psychiatric disability or mental illness judged by the practitioner to be clinically significant so as to preclude informed consent or compliance with procedures of study visits.
  • Cognitive impairment judged by the practitioner to be significant so as to preclude informed consent or compliance with procedures of study visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: QA-DDS
Patients will receive exposure to the QA-DDS tool from their dental care practitioner.
QuitAdvisorDDS is a point-of-care software tool to facilitate implementation of evidence-based tobacco treatment interventions in dental care settings.
Other Names:
  • QuitAdvisorDDS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Patient Acceptability A: Rate of Patient Wanting Provider to Use QA-DDS
Time Frame: Immediately Post-Consultation up to 1 week
80% of participating patients must indicate that they would want their dental practitioner to continue to use QA-DDS.
Immediately Post-Consultation up to 1 week
Primary Patient Acceptability B: Rate of Patient Wanting to Use QA-DDS Patient Portal
Time Frame: 1-Month Follow-Up
80% of participating patients must indicate that they would want to continue to use the QA-DDS Patient Portal.
1-Month Follow-Up
Primary Patient Feasibility A: Rate of Patient Completion of 1-Month Follow-Up Survey
Time Frame: 1-Month Follow-Up
80% of the enrolled dental care patients must complete the 1-month follow-up survey with the 7-day point prevalence measure of self-reported smoking status.
1-Month Follow-Up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary Patient Acceptability A: Average QA-DDS Satisfaction Ratings Among Patients on 0-10 Scale
Time Frame: Immediately Post-Consultation up to 1 week
Average QA-DDS satisfaction ratings among enrolled dental patients must be 7 or greater on a 0-10 scale.
Immediately Post-Consultation up to 1 week
Secondary Patient Feasibility A: Rate of Patient Accrual by Study Practices
Time Frame: 4-Month Follow-Up
75% of the study practices must recruit 10 eligible dental patients within a 4-month recruitment phase
4-Month Follow-Up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tertiary Patient Acceptability A1: Number of Patients Who Visit QA-DDS Patient Portal
Time Frame: 1-Month Follow-Up
To evaluate the acceptability of the QA-DDS Patient Portal among enrolled dental patients, the percentage of enrolled patients who make at least one visit to the Patient Portal will be monitored
1-Month Follow-Up
Tertiary Patient Acceptability A2: Number of Visits to QA-DDS Patient Portal Per Patient
Time Frame: 1-Month Follow-Up
To evaluate the acceptability of the QA-DDS Patient Portal among enrolled dental patients, the number of visits to the Patient Portal per patient will be monitored
1-Month Follow-Up
Tertiary Patient Acceptability B: Rate of QA-DDS Text Messaging Support Service Use as Measured by Number of Patient Subscriptions
Time Frame: 1-Month Follow-Up
To evaluate the acceptability of the QA-DDS Text Messaging Support Service, the percentage of enrolled patients who subscribe to the Text Messaging Support Service will be monitored.
1-Month Follow-Up
Tertiary Patient Feasibility A: Rate of Missing Data for Tobacco Use Among Patients
Time Frame: 1-Month Follow-Up
Self-reported measures of tobacco use and history at the follow-up assessment must have less than 10% missing data among responding dental patients.
1-Month Follow-Up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jamie L Studts, PhD, Associate Professor, University of Kentucky College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

October 3, 2015

First Submitted That Met QC Criteria

October 5, 2015

First Posted (Estimate)

October 7, 2015

Study Record Updates

Last Update Posted (Actual)

April 3, 2019

Last Update Submitted That Met QC Criteria

April 1, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 10-155-E
  • R44DE021327 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Use

Clinical Trials on QA-DDS

3
Subscribe